News
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the Investigational New ...
Invion (ASX:IVX) is progressing its Photosoft™ drug platform, designed to kill cancer cells when activated by light, through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback